Clinical Trials for Anaplastic Large Cell Lymphoma

Find clinical trials for anaplastic large cell lymphoma. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)

NCT ID: NCT07001384

This clinical trial is investigating the combination of two medications, alectinib and duvelisib, to see if they are safe and effective for treating adults with a type of lymphoma called anaplastic...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Middletown, New Jersey, United States +5 more

DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

NCT ID: NCT05770037

The DETERMINE Trial is studying a drug called alectinib, which is already used to treat certain types of lung cancer in adults. Researchers want to see if this medication can also help treat other ...

Recruiting

Phase: PHASE2 Type: interventional Locations: London, , United Kingdom, Leeds, , United Kingdom +26 more

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

NCT ID: NCT04195633

This clinical trial is studying a new treatment approach for patients with various types of blood cancers, such as acute leukemia and lymphoma. The treatment combines a donor stem cell transplant w...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

NCT ID: NCT06508463

This clinical trial is investigating a new treatment approach for patients with certain types of T-cell lymphoma, such as peripheral T-cell lymphoma and anaplastic large cell lymphoma. The treatmen...

Recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States, Rochester, Minnesota, United States

A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma

NCT ID: NCT06494371

This clinical trial is studying a new treatment called LCAR-HL30 for adults with certain types of blood cancer, specifically relapsed or refractory Hodgkin's lymphoma and Anaplastic large cell lymp...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China

CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas

NCT ID: NCT03383965

This clinical trial is studying a new treatment called ICAR30, which is designed to target and kill cancer cells that express a protein called CD30. The trial focuses on patients with Hodgkin lymph...

Recruiting

Phase: PHASE1 Type: interventional Locations: Weifang, Shandong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions